News for 'Safety Research'

Scientists urge caution over launch of Covid vaccine by Aug 15

Scientists urge caution over launch of Covid vaccine by Aug 15

Rediff.com4 Jul 2020

'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'

ASK MAYANK: I've a new job offer, should I take it?

ASK MAYANK: I've a new job offer, should I take it?

Rediff.com7 Apr 2021

How do you decide if you should take up a new job in these difficult times? HR guru Mayank Rautela has some tips that could help you decide.

This weapon scanned the sky for drones during PM's speech

This weapon scanned the sky for drones during PM's speech

Rediff.com15 Aug 2020

Prime Minister Narendra Modi had hoisted the national flag and addressed the nation from the ramparts of the Red Fort. He said that it was an occasion to remember freedom fighters who laid down their lives for the freedom of the country.

Phase II trial finds Chinese COVID-19 vaccine is safe

Phase II trial finds Chinese COVID-19 vaccine is safe

Rediff.com21 Jul 2020

Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.

Can't throw out plea of doctors' associations against Ramdev: HC

Can't throw out plea of doctors' associations against Ramdev: HC

Rediff.com25 Oct 2021

"The allegations may be right or maybe wrong. He may say he did not say any such thing... It needs to be looked into," said the judge.

Moderna says its COVID-19 vaccine is 94.5% effective

Moderna says its COVID-19 vaccine is 94.5% effective

Rediff.com16 Nov 2020

Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Rediff.com6 Oct 2020

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.

Covaxin launch now depends on clinical sites' deadline

Covaxin launch now depends on clinical sites' deadline

Rediff.com9 Jul 2020

There are 12 sites across India, including private and public hospitals, conducting Phase 1 and 2 human clinical trials for Bharat Biotech's Covaxin. Based on an earlier letter by the Indian Council of Medical Research (ICMR) to the 12 sites, volunteer recruitments for the clinical trials were to begin by July 7. At least three sites are yet to kick-start the process.

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

Despite controversies India sees widespread use of HCQ

Despite controversies India sees widespread use of HCQ

Rediff.com9 Jun 2020

Once touted as a 'wonder drug', HCQ has been battling global controversies around its safety and efficacy as a prophylactic against the new coronavirus SARS-CoV-2.

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Rediff.com16 Sep 2020

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India, RDIF and Dr Reddy's said in a joint statement.

'We've made a better film than Baahubali'

'We've made a better film than Baahubali'

Rediff.com10 Jan 2022

'Expectations do not intimidate me. In fact, they strengthen me.'

Modiji, we are going to die: A Bihar nurse's terrified plea

Modiji, we are going to die: A Bihar nurse's terrified plea

Rediff.com30 Mar 2020

A staff nurse from a Bihar hospital begs the prime minister for her life as the state's medical staff continues to treat suspected COVID-19 patients without protective safety kits.

CATS: India's Secret Weapon

CATS: India's Secret Weapon

Rediff.com11 Jan 2022

Burned by the shooting down of a MiG-21 aircraft and the capture of its pilot after a dogfight over the India-Pakistan border in February 2019, CATS eliminates the need to send pilots into enemy air space.

Indian pharma firms working on new repurposed drug for Covid-19

Indian pharma firms working on new repurposed drug for Covid-19

Rediff.com2 Sep 2020

Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations.

Bharat Biotech's Covid vaccine gets nod for Phase 3 trial

Bharat Biotech's Covid vaccine gets nod for Phase 3 trial

Rediff.com23 Oct 2020

The phase 3 clinical trial will cover around 28,500 subjects, aged 18 years and above, and it will be conducted in 21 sites across ten states, including Delhi, Mumbai, Patna and Lucknow.

PM reviews preparations for vaccination against COVID-19

PM reviews preparations for vaccination against COVID-19

Rediff.com30 Jun 2020

The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.

In major R&D push, Mercedes plans to step on the gas

In major R&D push, Mercedes plans to step on the gas

Rediff.com18 Nov 2016

The luxury car maker plans to recruit 1,000 people next year; in five years, research staff had jumped from 700 to 3,500.

How house designs are changing post Covid

How house designs are changing post Covid

Rediff.com11 Jul 2021

Realty - Sunday

India may ease clinical trial norms for coronavirus vaccine

India may ease clinical trial norms for coronavirus vaccine

Rediff.com1 Apr 2020

The Central Drugs Standard Control Organisation said while the rights, safety, and well-being of trial subjects were of paramount importance, protocol amendment, deviation or modification might be necessary in some cases owing to unavoidable circumstances.

96,000 vaccinators trained for world's largest immunisation exercise

96,000 vaccinators trained for world's largest immunisation exercise

Rediff.com1 Jan 2021

Of the 23.9 million vaccinators who provide vaccination under the universal immunisation programme, 15.4 million will be used for Covid vaccination.

How India can protect itself from cyber attacks

How India can protect itself from cyber attacks

Rediff.com18 Mar 2021

The recent report in the New York Times that China had brought India's financial capital - Mumbai - to a halt by hacking the electricity supply grid has not come as a surprise to the CTOs (chief technology officers) and cyber security experts. Indian companies, including critical infrastructure providers such as power grids, ports and radar systems, lack the IT infrastructure to prevent hacking from hostile state actors like China and North Korea, warn security experts. Recently, the United States government warned of yet another breach of critical systems tied to Microsoft Exchange email systems that the company has blamed on China. The breach has impacted thousands of organisations in the US and its impact on India is still unknown.

FM allocates Rs 35,000 crores for COVID-19 vaccine

FM allocates Rs 35,000 crores for COVID-19 vaccine

Rediff.com1 Feb 2021

The Budget outlay for health and well being is Rs 2.23 lakh crore in 2021-22 as against BE of Rs 94,452 crore and marks an increase of 137 per cent," she said while presenting 2021-22 Budget in the Lok Sabha.

Indians more vulnerable to tech support scams, says Microsoft report

Indians more vulnerable to tech support scams, says Microsoft report

Rediff.com23 Jul 2021

Indians are more vulnerable to technology support-related scams compared to the global average, and lost over Rs 15,000 on average in such scam, a Microsoft research has found. According to the 2021 Global Tech Support Scam Research report, which looks at tech support scams and their impact, consumers in India experienced a relatively high scam encounter rate of 69 per cent during the past 12 months, close to the 70 per cent rate experienced in 2018. In contrast, there was an overall five-point drop in scam encounters globally with a rate of 59 per cent over the same period. The survey was conducted in Spring 2021 and asked consumers to share their experiences with tech support scams for the year prior (January 2020 to present).

Travelling solo? You must inspect your room first

Travelling solo? You must inspect your room first

Rediff.com2 Mar 2019

Safety and security are important factors when it comes to looking for lodging and accommodation, says Sagar Panchal.

MPs will need COVID negative report for Parliament

MPs will need COVID negative report for Parliament

Rediff.com4 Sep 2020

The COVID-19 test of the MPs need to be done 72 hours before the start of the session and it can be done either in their constituencies or at the Parliament complex.

How crash-worthy is your India-made car?

How crash-worthy is your India-made car?

Rediff.com9 Jan 2019

The Tata Nexon and Mahindra Marazzo ace the safety ratings, but what about other Made in India cars? How safe is the car you drive?

Sensex catches global 'flu'; ends in red for 5th day

Sensex catches global 'flu'; ends in red for 5th day

Rediff.com27 Feb 2020

ONGC was the top loser in the Sensex pack, followed by HCL Tech, SBI, ICICI Bank, IndusInd Bank, Hero MotoCorp and M&M.

Afghan withdrawal best decision for US: Biden

Afghan withdrawal best decision for US: Biden

Rediff.com1 Sep 2021

"After 20 years of war in Afghanistan, I refused to send another generation of America's sons and daughters to fight a war that should have ended long ago," US President Joe Biden.

Covid vaccine possible by 2021 first quarter: Vardhan

Covid vaccine possible by 2021 first quarter: Vardhan

Rediff.com13 Sep 2020

Vardhan stated the government is taking full precautions in human trials of vaccines and the National Expert Group on Vaccine Administration for COVID-19 under the chairmanship of Dr V K Paul, member-health, NITI Aayog, is drawing up a detailed strategy on how to immunize the majority of the population.

More Covid vaccine candidates get approval for clinical trials in India

More Covid vaccine candidates get approval for clinical trials in India

Rediff.com6 Feb 2021

Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.

Top medical body favours phased school reopening

Top medical body favours phased school reopening

Rediff.com28 Sep 2021

Evidence indicates that restoration of functioning of the education system as it was in pre-Covid times, as early as possible appears prudent in the current Indian context, they said.

Scientists sceptical about Russia's COVID-19 vaccine

Scientists sceptical about Russia's COVID-19 vaccine

Rediff.com12 Aug 2020

Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.

AAP's manifesto focuses on free water, cheap bijli and women's safety

AAP's manifesto focuses on free water, cheap bijli and women's safety

Rediff.com31 Jan 2015

Releasing its 70-point programme, Kejriwal called party's manifesto 'holy'.

Pvt sector to be allowed to build rockets: ISRO chief Sivan

Pvt sector to be allowed to build rockets: ISRO chief Sivan

Rediff.com25 Jun 2020

Sivan said the Indian National Space Promotion and Authorisation Centre (In-Space) has been created under the Department of Space as a separate vertical for taking independent decisions with respect to permitting and regulating space activities of the private sector.

COVID risk in planes, restaurants can't be compared: Scientists

COVID risk in planes, restaurants can't be compared: Scientists

Rediff.com1 Nov 2020

While a recent study has claimed that dining out, and grocery shopping could be more dangerous than air travel during the COVID-19 pandemic, partly due to special ventilation systems in airplanes, some scientists say such a comparison cannot be made without knowing if mask-wearing and social distancing norms are properly followed in each of these scenarios.

UK signs deal for 90 million COVID-19 vaccine doses

UK signs deal for 90 million COVID-19 vaccine doses

Rediff.com20 Jul 2020

To enable large-scale vaccine studies to take place across the UK, the aim is to get 500,000 people signed up by October, which is considered vital in the fight against coronavirus.

First COVID-19 vaccine human trial finds it's safe

First COVID-19 vaccine human trial finds it's safe

Rediff.com23 May 2020

The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research published in The Lancet journal.

UGC issues guidelines for reopening colleges, varsities

UGC issues guidelines for reopening colleges, varsities

Rediff.com6 Nov 2020

Following a six-day schedule, reducing class size, setting up isolation facilities on campus, and COVID-19 screening of students, faculty and staff are among the guidelines announced by the University Grants Commission (UGC) for reopening of universities and colleges closed since March in view of the pandemic.

Who shouldn't take jab? Vaccine makers issue fact sheet

Who shouldn't take jab? Vaccine makers issue fact sheet

Rediff.com19 Jan 2021

The fact sheet also asked people to inform the vaccinator or a supervising official about their medical condition before taking the vaccine.